Biological and clinical evidence for somatic mutations in BRCA1 and BRCA2 as predictive markers for olaparib response in high-grade serous ovarian cancers in the maintenance setting.
about
Olaparib and somatic BRCA mutations.Detection of BRCA1/2 mutations in circulating tumor DNA from patients with ovarian cancer.Candidate synthetic lethality partners to PARP inhibitors in the treatment of ovarian clear cell cancer.An evaluation of the challenges to developing tumor BRCA1 and BRCA2 testing methodologies for clinical practice.PARP inhibitors as potential therapeutic agents for various cancers: focus on niraparib and its first global approval for maintenance therapy of gynecologic cancers.PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer.Next-generation Sequencing Reveals Recurrent Somatic Mutations in Small Cell Neuroendocrine Carcinoma of the Uterine Cervix.Tumor evolution and chemoresistance in ovarian cancer
P2860
Q42343103-D540E03E-F80F-4123-8CA7-04BD04F2F520Q47115415-F67F4B0D-3F01-47A4-B8CF-C2171A470EE3Q47122646-A1789C20-FB6B-4421-A87B-F8E44F4E436BQ47351280-6269219D-9FBE-4BFB-B364-D5E3A7FC3049Q48164214-99C19CE0-2CD1-46A9-B77B-3DD1853D30E8Q49723005-DCF14701-C356-4147-8D66-C9A66ED077B1Q54096033-A8F75DD8-3216-4C7F-8021-448F988536E8Q58733743-09927185-6DAB-4F19-B545-3A8DCEF1D1C2
P2860
Biological and clinical evidence for somatic mutations in BRCA1 and BRCA2 as predictive markers for olaparib response in high-grade serous ovarian cancers in the maintenance setting.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Biological and clinical eviden ...... rs in the maintenance setting.
@en
type
label
Biological and clinical eviden ...... rs in the maintenance setting.
@en
prefLabel
Biological and clinical eviden ...... rs in the maintenance setting.
@en
P2093
P2860
P356
P1433
P1476
Biological and clinical eviden ...... rs in the maintenance setting.
@en
P2093
Anitra Fielding
Brian A Dougherty
Darren R Hodgson
J Carl Barrett
Jane D Robertson
Jonathan A Ledermann
Maria C M Orr
Matthew Hawryluk
Roman Yelensky
P2860
P304
43653-43661
P356
10.18632/ONCOTARGET.17613
P407
P577
2017-05-04T00:00:00Z